(Q30651159)

English

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 June 2017

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. (English)

1 reference

Europe PubMed Central

25 June 2017

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

4

object named as

R R Holman

1 reference

Europe PubMed Central

25 June 2017

author name string

A J Hayes

1

1 reference

Europe PubMed Central

25 June 2017

J Leal

2

1 reference

Europe PubMed Central

25 June 2017

A M Gray

3

1 reference

Europe PubMed Central

25 June 2017

P M Clarke

5

1 reference

Europe PubMed Central

25 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

22 June 2013

1 reference

Europe PubMed Central

25 June 2017

1 reference

Europe PubMed Central

25 June 2017

56

1 reference

Europe PubMed Central

25 June 2017

1925-1933

1 reference

Europe PubMed Central

25 June 2017

9

1 reference

Europe PubMed Central

25 June 2017

https://scigraph.springernature.com/pub.10.1007/s00125-013-2940-y

0 references

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Development of life-expectancy tables for people with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Monitoring kidney function and albuminuria in patients with diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Guidelines for computer modeling of diabetes and its complications

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Validation of population-based disease simulation models: a review of concepts and methods

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2940-Y

21 January 2018

Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6

1 reference

https://pubmed.ncbi.nlm.nih.gov/23793713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transparency and reproducible research in modeling: why we need it and how to get there

1 reference

https://pubmed.ncbi.nlm.nih.gov/23793713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23793713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data

1 reference

https://pubmed.ncbi.nlm.nih.gov/23793713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

1 reference

https://pubmed.ncbi.nlm.nih.gov/23793713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/23793713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-013-2940-Y

1 reference

Europe PubMed Central

25 June 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30651159&oldid=1606111440"